Journey Medical Corporation (DERM)

Journey Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	20.29	20.31	27.44	32	49.08	8.25
Cash & Short-Term Investments	20.29	20.31	27.44	32	49.08	8.25
Cash Growth	-15.14%	-26.00%	-14.26%	-34.80%	495.21%	71.76%
Receivables	15.64	10.23	15.22	28.21	23.11	23.93
Inventory	12.85	14.43	10.21	14.16	9.86	1.4
Prepaid Expenses	2.48	3.21	3.59	3.31	2.44	1.66
Total Current Assets	51.27	48.18	56.46	77.68	84.49	35.24
Property, Plant & Equipment	0.16	0.2	0.1	0.19	0.09	0.18
Other Intangible Assets	29.73	31.86	20.29	27.2	12.55	15.03
Long-Term Deferred Tax Assets	-	-	-	-	-	1.45
Other Long-Term Assets	-	-	0.01	0.1	0.15	0.01
Total Assets	81.16	80.24	76.85	105.16	97.28	51.91
Accounts Payable	12.75	16.05	18.15	36.57	22.81	1.86
Accrued Expenses	21.31	15.23	16.49	16.27	20.09	19.02
Short-Term Debt	-	-	-	2.95	0.81	-
Current Portion of Long-Term Debt	3.75	0.63	3	2.24	4.51	4.52
Current Portion of Leases	0.1	0.08	0.1	0.08	0.1	0.09
Current Income Taxes Payable	0.07	0.06	0.05	0.04	0.01	-
Other Current Liabilities	2.5	3.12	4.08	8.68	3.28	2.58
Total Current Liabilities	40.48	35.18	41.87	66.83	51.61	28.06
Long-Term Debt	21.36	24.88	14.62	21.24	3.63	13.36
Long-Term Leases	0.07	0.12	0.01	0.11	-	0.1
Other Long-Term Liabilities	-	-	-	-	-	0.1
Total Liabilities	61.91	60.17	56.5	88.18	55.24	41.61
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	114.14	107.09	92.7	85.48	80.92	5.17
Retained Earnings	-94.9	-87.03	-72.36	-68.5	-38.87	5.12
Shareholders' Equity	19.25	20.07	20.35	16.98	42.04	10.29
Total Liabilities & Equity	81.16	80.24	76.85	105.16	97.28	51.91
Total Debt	25.28	25.71	17.73	26.62	9.05	18.06
Net Cash (Debt)	-4.98	-5.4	9.71	5.38	40.03	-9.82
Net Cash Growth	-	-	80.40%	-86.56%	-	-
Net Cash Per Share	-0.23	-0.26	0.53	0.31	3.93	-0.91
Filing Date Shares Outstanding	24.38	23.1	19.93	17.83	17.32	9.15
Total Common Shares Outstanding	23.47	22.15	19.32	17.77	17.32	9.15
Working Capital	10.79	13	14.59	10.85	32.88	7.18
Book Value Per Share	0.82	0.91	1.05	0.96	2.43	1.12
Tangible Book Value	-10.49	-11.79	0.06	-10.22	29.49	-4.74
Tangible Book Value Per Share	-0.45	-0.53	0.00	-0.57	1.70	-0.52

Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q